Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 917Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
REGULATORY UPDATE
Year : 2019  |  Volume : 10  |  Issue : 1  |  Page : 31-33

Indian regulatory update April–October 2018


1 Head Regulatory Affairs, Global Drug Development India, Novartis Healthcare Private Ltd., Mumbai, Maharashtra, India
2 General Regulator Affairs Manager, Johnson and Johnson Private Limited, Mumbai, Maharashtra, India

Correspondence Address:
Amita Bhave
Novartis Healthcare Private Limited, Inspire BKC, Part of 601 and 701, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/picr.PICR_188_18

Rights and Permissions

This document provides updates in regulatory requirements regarding conduct of clinical trials in India.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed476    
    Printed9    
    Emailed0    
    PDF Downloaded83    
    Comments [Add]    

Recommend this journal